Paper Details

  1. Home
  2. Paper Details

Medication non-adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.

Author: BayJacques-Olivier, BelaicheStephanie, BourhisJean-Henri, BrunoBénédicte, BulaboisClaude-Eric, CaronAlexandre, CeballosPatrice, CoiteuxValérie, ContentinNathalie, CornillonJérôme, De BerrangerEva, DepasNicolas, DécaudinBertrand, FargeDominique, FegueuxNathalie, GalambrunClaire, GandemerVirginie, HicheriYosr, HuynhAnne, LioureBruno, MagroLeonardo, MaillardNatacha, OdouPascal, PlantazDominique, RiallandFanny, SirventAnne, TaqueSophie, TurlurePascal, VignauxClaire, VigourouxStephane, VincentLaure, Yakoub-AghaIbrahim

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

Medication non-adherence after allogeneic hematopoietic cell transplantation is a serious concern, with an estimated 75% non-adherence rate in both adults and children in France. The study found that age was the only significant factor associated with non-adherence in adults, with younger patients being more likely to be non-adherent. Further research is needed to confirm these findings and investigate factors influencing non-adherence in children.
Paper Details　
Original Abstract of the Article :
Medication non-adherence (NA) after allogeneic hematopoietic cell transplantation (allo-HCT) can lead to serious complications. This study assesses NA in French adult and pediatric recipients and identifies factors associated with NA. In accordance with the EMERGE and STROBE guidelines, a cross sect...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/fcp.12593

データ提供：米国国立医学図書館（NLM）

Medication Adherence After Hematopoietic Cell Transplantation

Allogeneic hematopoietic cell transplantation (allo-HCT) is a complex procedure that requires careful medication management to ensure successful recovery. This cross-sectional study assessed medication non-adherence (NA) in adult and pediatric recipients of allo-HCT in France. The researchers found that NA was high in both populations, with age being a significant factor in adults. The study also identified other factors associated with NA, including specific medications and the experience of side effects.

Navigating the Challenges of Medication Adherence

This study highlights the challenges of medication adherence after allo-HCT, underscoring the importance of patient education, support, and personalized care. It's like navigating a winding desert trail, where careful attention to detail is crucial for success. The researchers identified several factors that influence adherence, providing valuable insights for healthcare providers to address and improve patient outcomes.

Ensuring Success After Transplantation

This study emphasizes the need for a multi-faceted approach to managing medication adherence after allo-HCT. It's like creating a sustainable oasis in the desert, requiring careful planning and implementation. By addressing factors such as age, medication choice, and side effects, healthcare providers can work to improve adherence and maximize the success of this life-saving procedure.

Dr.Camel's Conclusion

This study highlights the importance of medication adherence in ensuring the success of allo-HCT. It's like finding a hidden water source in the desert, a vital resource that sustains life. By recognizing the factors that can influence adherence, healthcare providers can offer individualized support to patients, ensuring they stay on track and maximize their chances of a successful recovery.

Date :
  1. Date Completed 2021-10-08
  2. Date Revised 2021-10-08
Further Info :

Pubmed ID

32740936

DOI: Digital Object Identifier

10.1111/fcp.12593

Related Literature

Article Analysis
・Side Effects of valacyclovir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.